American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S71-S77 , March 2009

Who Should Be Targeted for CKD Screening? Impact of Diabetes, Hypertension, and Cardiovascular Disease

  • Allan J. Collins, MD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • Department of Medicine, University of Minnesota, Minneapolis, MN
    • Corresponding Author InformationAddress correspondence to Allan J. Collins, MD, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th St, Ste S-406, Minneapolis, MN 55404
  • ,
  • Joseph A. Vassalotti, MD

      Affiliations

    • National Kidney Foundation, New York, NY
    • Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, NY
  • ,
  • Changchun Wang, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Suying Li, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • David T. Gilbertson, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Jiannong Liu, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Robert N. Foley, MB

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • Department of Medicine, University of Minnesota, Minneapolis, MN
  • ,
  • Shu-Cheng Chen, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
  • ,
  • Thomas J. Arneson, MD, MPH

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN

References 

  1. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  3. US Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  5. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869
  6. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860
  7. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  8. Bang H, Vupputuri S, Shoham DA, et al. Screening for Occult Renal Disease (SCORED): A simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–381
  9. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Analytic and Reporting Guidelines. http://www.cdc.gov/nchs/nhanes.htmAccessed May 13, 2008
  10. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES tutorials). http://www.cdc.gov/nchs/nhanes.htmAccessed May 13, 2008
  11. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  12. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Correction for Serum Creatinine for NHANES 1999-2000 Is Highly Recommended. http://www.cdc.gov/nchs/data/nhanes/frequency/lab18_doc.pdfAccessed May 13, 2008
  13. National Center for Health Statistics: National Health and Nutrition Examination Survey (NHANES). Follicle Stimulating Hormone, and Luteinizing Hormone. http://www.cdc.gov/nchs/data/nhanes/nhanes_01_02/l40_b_doc.pdfAccessed May 13, 2008
  14. National Center for Health Statistics: NHANES. Documentation, Codebook, and Frequencies. http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l40_c.pdfAccessed May 13, 2008
  15. National Center for Health Statistics CfDCaP. The National Health and Nutrition Examination Survey (NHANES), Analytic and Reporting Guidelines. http://www.cdc.gov/nchs/hus.htmAccessed May 13, 2008
  16. National Kidney Foundation. KEEP (Kidney Early Evaluation Program) Annual Data Report 2006. Am J Kidney Dis. 2007;49:S1–S160(suppl 1)
  17. Boulware LE, Jaar BG, Tarver-Carr ME, et al. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA. 2003;290:3101–3114
  18. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2007;30:S4–S41(suppl 1)
  19. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diabetes Vasc Dis Res. 2007;4:285–296
  20. Del-Rio-Navarro BE, Velazquez-Monroy O, Lara-Esqueda A, et al. Obesity and metabolic risks in children. Arch Med Res. 2008;39:215–221
  21. Abell JE, Egan BM, Wilson PW, et al. Differences in cardiovascular disease mortality associated with body mass between black and white persons. Am J Public Health. 2008;98:63–66
  22. Johnson-Taylor WL, Fisher RA, Hubbard VS, et al. The change in weight perception of weight status among the overweight: Comparison of NHANES III (1988-1994) and 1999-2004 NHANES. Int J Behav Nutr Phys Act. 2008;5:9

PII: S0272-6386(08)01744-7

doi: 10.1053/j.ajkd.2008.07.057

American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S71-S77 , March 2009